Fluorine in PDB 8hkn: Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
Enzymatic activity of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
All present enzymatic activity of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib:
2.4.2.30;
Protein crystallography data
The structure of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib, PDB code: 8hkn
was solved by
X.Y.Wang,
J.Zhou,
B.L.Xu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
36.98 /
2.50
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
41.01,
85.584,
95.413,
90,
90.03,
90
|
R / Rfree (%)
|
18.2 /
26.1
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
(pdb code 8hkn). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 8 binding sites of Fluorine where determined in the
Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib, PDB code: 8hkn:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Fluorine binding site 1 out
of 8 in 8hkn
Go back to
Fluorine Binding Sites List in 8hkn
Fluorine binding site 1 out
of 8 in the Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F602
b:43.1
occ:1.00
|
F01
|
B:25I602
|
0.0
|
43.1
|
1.0
|
C15
|
B:25I602
|
1.3
|
39.2
|
1.0
|
F03
|
B:25I602
|
2.2
|
44.6
|
1.0
|
F02
|
B:25I602
|
2.2
|
45.1
|
1.0
|
C14
|
B:25I602
|
2.3
|
35.1
|
1.0
|
N03
|
B:25I602
|
2.7
|
29.8
|
1.0
|
OH
|
B:TYR279
|
3.0
|
26.7
|
1.0
|
O
|
B:HOH707
|
3.3
|
33.1
|
1.0
|
N04
|
B:25I602
|
3.4
|
34.0
|
1.0
|
O
|
B:HOH748
|
3.6
|
27.2
|
1.0
|
O
|
B:HOH745
|
3.7
|
40.4
|
1.0
|
O
|
B:HOH761
|
3.7
|
38.4
|
1.0
|
C13
|
B:25I602
|
3.9
|
28.8
|
1.0
|
CB
|
B:GLU335
|
3.9
|
29.3
|
1.0
|
CG
|
B:GLU335
|
4.0
|
34.3
|
1.0
|
CA
|
B:GLU335
|
4.1
|
28.5
|
1.0
|
N02
|
B:25I602
|
4.2
|
29.1
|
1.0
|
CZ
|
B:TYR279
|
4.2
|
27.2
|
1.0
|
CD
|
B:PRO447
|
4.3
|
33.2
|
1.0
|
CA
|
B:ALA446
|
4.5
|
29.1
|
1.0
|
CD
|
B:GLU335
|
4.6
|
39.2
|
1.0
|
OE1
|
B:GLU335
|
4.8
|
42.3
|
1.0
|
CB
|
B:ALA446
|
4.8
|
28.9
|
1.0
|
N
|
B:GLU335
|
4.9
|
27.1
|
1.0
|
CE1
|
B:TYR279
|
5.0
|
26.1
|
1.0
|
|
Fluorine binding site 2 out
of 8 in 8hkn
Go back to
Fluorine Binding Sites List in 8hkn
Fluorine binding site 2 out
of 8 in the Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F602
b:45.1
occ:1.00
|
F02
|
B:25I602
|
0.0
|
45.1
|
1.0
|
C15
|
B:25I602
|
1.3
|
39.2
|
1.0
|
F03
|
B:25I602
|
2.1
|
44.6
|
1.0
|
F01
|
B:25I602
|
2.2
|
43.1
|
1.0
|
C14
|
B:25I602
|
2.3
|
35.1
|
1.0
|
O
|
B:HOH761
|
2.6
|
38.4
|
1.0
|
N04
|
B:25I602
|
2.7
|
34.0
|
1.0
|
NH2
|
B:ARG444
|
3.2
|
50.2
|
1.0
|
N03
|
B:25I602
|
3.5
|
29.8
|
1.0
|
CZ
|
B:ARG444
|
3.7
|
47.7
|
1.0
|
N02
|
B:25I602
|
3.9
|
29.1
|
1.0
|
O
|
B:HOH745
|
4.1
|
40.4
|
1.0
|
NE
|
B:ARG444
|
4.1
|
47.3
|
1.0
|
CG
|
B:GLU335
|
4.2
|
34.3
|
1.0
|
NH1
|
B:ARG444
|
4.3
|
47.7
|
1.0
|
O
|
B:HOH792
|
4.3
|
33.4
|
1.0
|
C13
|
B:25I602
|
4.3
|
28.8
|
1.0
|
CB
|
B:ARG444
|
4.5
|
37.2
|
1.0
|
O
|
B:HOH740
|
4.6
|
50.3
|
1.0
|
OH
|
B:TYR279
|
4.7
|
26.7
|
1.0
|
CB
|
B:GLU335
|
4.8
|
29.3
|
1.0
|
CA
|
B:GLU335
|
4.8
|
28.5
|
1.0
|
O
|
B:HOH768
|
4.9
|
39.4
|
1.0
|
O
|
B:GLU335
|
4.9
|
23.9
|
1.0
|
CD
|
B:GLU335
|
4.9
|
39.2
|
1.0
|
|
Fluorine binding site 3 out
of 8 in 8hkn
Go back to
Fluorine Binding Sites List in 8hkn
Fluorine binding site 3 out
of 8 in the Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F602
b:44.6
occ:1.00
|
F03
|
B:25I602
|
0.0
|
44.6
|
1.0
|
C15
|
B:25I602
|
1.3
|
39.2
|
1.0
|
F02
|
B:25I602
|
2.1
|
45.1
|
1.0
|
F01
|
B:25I602
|
2.2
|
43.1
|
1.0
|
C14
|
B:25I602
|
2.4
|
35.1
|
1.0
|
N03
|
B:25I602
|
3.2
|
29.8
|
1.0
|
N04
|
B:25I602
|
3.2
|
34.0
|
1.0
|
O
|
B:HOH768
|
3.4
|
39.4
|
1.0
|
CA
|
B:ALA446
|
3.6
|
29.1
|
1.0
|
O
|
B:ILE445
|
3.7
|
32.3
|
1.0
|
CD
|
B:PRO447
|
3.8
|
33.2
|
1.0
|
N
|
B:ALA446
|
3.9
|
29.6
|
1.0
|
C
|
B:ILE445
|
3.9
|
31.5
|
1.0
|
C13
|
B:25I602
|
4.2
|
28.8
|
1.0
|
N02
|
B:25I602
|
4.2
|
29.1
|
1.0
|
CB
|
B:ARG444
|
4.3
|
37.2
|
1.0
|
N
|
B:PRO447
|
4.4
|
29.2
|
1.0
|
C
|
B:ALA446
|
4.4
|
30.3
|
1.0
|
O
|
B:HOH761
|
4.5
|
38.4
|
1.0
|
CB
|
B:ALA446
|
4.5
|
28.9
|
1.0
|
OH
|
B:TYR279
|
4.5
|
26.7
|
1.0
|
O
|
B:ARG444
|
4.6
|
27.1
|
1.0
|
C
|
B:ARG444
|
4.7
|
31.4
|
1.0
|
CZ
|
B:ARG444
|
4.7
|
47.7
|
1.0
|
NH2
|
B:ARG444
|
4.8
|
50.2
|
1.0
|
O
|
B:HOH745
|
4.8
|
40.4
|
1.0
|
NH1
|
B:ARG444
|
4.9
|
47.7
|
1.0
|
CG
|
B:PRO447
|
4.9
|
31.8
|
1.0
|
N
|
B:ILE445
|
4.9
|
29.6
|
1.0
|
NE
|
B:ARG444
|
5.0
|
47.3
|
1.0
|
|
Fluorine binding site 4 out
of 8 in 8hkn
Go back to
Fluorine Binding Sites List in 8hkn
Fluorine binding site 4 out
of 8 in the Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F602
b:28.6
occ:1.00
|
F04
|
B:25I602
|
0.0
|
28.6
|
1.0
|
C16
|
B:25I602
|
1.4
|
28.1
|
1.0
|
C17
|
B:25I602
|
2.4
|
28.6
|
1.0
|
C08
|
B:25I602
|
2.4
|
25.3
|
1.0
|
C10
|
B:25I602
|
2.8
|
27.7
|
1.0
|
C09
|
B:25I602
|
3.0
|
24.8
|
1.0
|
N01
|
B:25I602
|
3.1
|
25.0
|
1.0
|
CE1
|
B:TYR462
|
3.2
|
28.4
|
1.0
|
O
|
B:GLY460
|
3.2
|
26.4
|
1.0
|
CD1
|
B:TYR462
|
3.3
|
26.8
|
1.0
|
CD2
|
B:TYR455
|
3.4
|
26.3
|
1.0
|
O
|
B:HOH735
|
3.6
|
32.8
|
1.0
|
C07
|
B:25I602
|
3.7
|
26.9
|
1.0
|
C18
|
B:25I602
|
3.7
|
27.1
|
1.0
|
CE2
|
B:TYR455
|
3.8
|
25.6
|
1.0
|
O02
|
B:25I602
|
4.0
|
22.5
|
1.0
|
CZ
|
B:TYR462
|
4.1
|
29.8
|
1.0
|
O3
|
B:GOL601
|
4.1
|
56.9
|
1.0
|
C06
|
B:25I602
|
4.2
|
25.4
|
1.0
|
C13
|
B:25I602
|
4.2
|
28.8
|
1.0
|
C
|
B:GLY460
|
4.3
|
23.6
|
1.0
|
CG
|
B:TYR462
|
4.3
|
25.6
|
1.0
|
C11
|
B:25I602
|
4.3
|
26.6
|
1.0
|
N
|
B:GLY460
|
4.5
|
25.7
|
1.0
|
CG
|
B:TYR455
|
4.6
|
27.9
|
1.0
|
O
|
B:GLY458
|
4.6
|
23.4
|
1.0
|
OH
|
B:TYR462
|
4.7
|
30.6
|
1.0
|
C3
|
B:GOL601
|
4.9
|
62.1
|
1.0
|
CE2
|
B:TYR462
|
4.9
|
27.4
|
1.0
|
CD2
|
B:TYR462
|
4.9
|
26.1
|
1.0
|
N03
|
B:25I602
|
5.0
|
29.8
|
1.0
|
C1
|
B:GOL601
|
5.0
|
60.7
|
1.0
|
|
Fluorine binding site 5 out
of 8 in 8hkn
Go back to
Fluorine Binding Sites List in 8hkn
Fluorine binding site 5 out
of 8 in the Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F602
b:44.8
occ:1.00
|
F01
|
A:25I602
|
0.0
|
44.8
|
1.0
|
C15
|
A:25I602
|
1.3
|
39.8
|
1.0
|
F02
|
A:25I602
|
2.1
|
38.1
|
1.0
|
F03
|
A:25I602
|
2.2
|
42.6
|
1.0
|
C14
|
A:25I602
|
2.4
|
35.1
|
1.0
|
N04
|
A:25I602
|
2.8
|
34.7
|
1.0
|
NH2
|
A:ARG444
|
3.3
|
47.1
|
1.0
|
CZ
|
A:ARG444
|
3.3
|
52.5
|
1.0
|
NH1
|
A:ARG444
|
3.4
|
45.0
|
1.0
|
N03
|
A:25I602
|
3.6
|
29.7
|
1.0
|
N02
|
A:25I602
|
4.0
|
31.2
|
1.0
|
NE
|
A:ARG444
|
4.0
|
46.5
|
1.0
|
O
|
A:HOH784
|
4.1
|
46.5
|
1.0
|
C3
|
A:GOL601
|
4.1
|
77.8
|
1.0
|
O
|
A:HOH743
|
4.2
|
49.5
|
1.0
|
O
|
A:HOH704
|
4.2
|
35.1
|
1.0
|
O3
|
A:GOL601
|
4.3
|
57.7
|
1.0
|
CB
|
A:ARG444
|
4.3
|
32.4
|
1.0
|
C13
|
A:25I602
|
4.4
|
30.4
|
1.0
|
O
|
A:HOH812
|
4.4
|
51.2
|
1.0
|
CD
|
A:ARG444
|
4.7
|
40.3
|
1.0
|
O
|
A:HOH758
|
4.9
|
38.7
|
1.0
|
O
|
A:ILE445
|
4.9
|
32.9
|
1.0
|
OH
|
A:TYR279
|
5.0
|
37.4
|
1.0
|
|
Fluorine binding site 6 out
of 8 in 8hkn
Go back to
Fluorine Binding Sites List in 8hkn
Fluorine binding site 6 out
of 8 in the Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F602
b:38.1
occ:1.00
|
F02
|
A:25I602
|
0.0
|
38.1
|
1.0
|
C15
|
A:25I602
|
1.3
|
39.8
|
1.0
|
F01
|
A:25I602
|
2.1
|
44.8
|
1.0
|
F03
|
A:25I602
|
2.2
|
42.6
|
1.0
|
C14
|
A:25I602
|
2.3
|
35.1
|
1.0
|
N03
|
A:25I602
|
3.1
|
29.7
|
1.0
|
N04
|
A:25I602
|
3.1
|
34.7
|
1.0
|
O
|
A:ILE445
|
3.2
|
32.9
|
1.0
|
O
|
A:HOH784
|
3.4
|
46.5
|
1.0
|
CA
|
A:ALA446
|
3.4
|
25.6
|
1.0
|
C
|
A:ILE445
|
3.7
|
30.6
|
1.0
|
N
|
A:ALA446
|
3.8
|
25.6
|
1.0
|
CD
|
A:PRO447
|
4.0
|
28.1
|
1.0
|
N02
|
A:25I602
|
4.1
|
31.2
|
1.0
|
C13
|
A:25I602
|
4.1
|
30.4
|
1.0
|
O
|
A:HOH812
|
4.1
|
51.2
|
1.0
|
CB
|
A:ARG444
|
4.2
|
32.4
|
1.0
|
C
|
A:ALA446
|
4.2
|
28.6
|
1.0
|
NH1
|
A:ARG444
|
4.3
|
45.0
|
1.0
|
O
|
A:ARG444
|
4.4
|
28.6
|
1.0
|
N
|
A:PRO447
|
4.4
|
27.4
|
1.0
|
CB
|
A:ALA446
|
4.4
|
27.9
|
1.0
|
C
|
A:ARG444
|
4.5
|
30.8
|
1.0
|
CZ
|
A:ARG444
|
4.6
|
52.5
|
1.0
|
O
|
A:HOH719
|
4.7
|
29.5
|
1.0
|
OH
|
A:TYR279
|
4.8
|
37.4
|
1.0
|
N
|
A:ILE445
|
4.8
|
31.6
|
1.0
|
CA
|
A:ILE445
|
4.9
|
31.8
|
1.0
|
O
|
A:HOH743
|
4.9
|
49.5
|
1.0
|
CA
|
A:ARG444
|
5.0
|
30.2
|
1.0
|
|
Fluorine binding site 7 out
of 8 in 8hkn
Go back to
Fluorine Binding Sites List in 8hkn
Fluorine binding site 7 out
of 8 in the Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 7 of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F602
b:42.6
occ:1.00
|
F03
|
A:25I602
|
0.0
|
42.6
|
1.0
|
C15
|
A:25I602
|
1.4
|
39.8
|
1.0
|
F01
|
A:25I602
|
2.2
|
44.8
|
1.0
|
F02
|
A:25I602
|
2.2
|
38.1
|
1.0
|
C14
|
A:25I602
|
2.4
|
35.1
|
1.0
|
N03
|
A:25I602
|
2.9
|
29.7
|
1.0
|
OH
|
A:TYR279
|
2.9
|
37.4
|
1.0
|
O
|
A:HOH743
|
3.2
|
49.5
|
1.0
|
O
|
A:HOH719
|
3.5
|
29.5
|
1.0
|
N04
|
A:25I602
|
3.6
|
34.7
|
1.0
|
CG
|
A:GLU335
|
3.8
|
38.6
|
1.0
|
CZ
|
A:TYR279
|
4.1
|
36.6
|
1.0
|
O
|
A:HOH812
|
4.1
|
51.2
|
1.0
|
C13
|
A:25I602
|
4.1
|
30.4
|
1.0
|
CA
|
A:GLU335
|
4.2
|
29.6
|
1.0
|
CD
|
A:PRO447
|
4.3
|
28.1
|
1.0
|
CB
|
A:GLU335
|
4.3
|
33.2
|
1.0
|
N02
|
A:25I602
|
4.4
|
31.2
|
1.0
|
CA
|
A:ALA446
|
4.6
|
25.6
|
1.0
|
CE2
|
A:TYR279
|
4.7
|
34.2
|
1.0
|
C3
|
A:GOL601
|
4.8
|
77.8
|
1.0
|
CD
|
A:GLU335
|
4.8
|
41.1
|
1.0
|
N
|
A:GLU335
|
4.8
|
29.9
|
1.0
|
CB
|
A:ALA446
|
4.9
|
27.9
|
1.0
|
OE2
|
A:GLU335
|
5.0
|
35.9
|
1.0
|
|
Fluorine binding site 8 out
of 8 in 8hkn
Go back to
Fluorine Binding Sites List in 8hkn
Fluorine binding site 8 out
of 8 in the Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 8 of Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F602
b:25.6
occ:1.00
|
F04
|
A:25I602
|
0.0
|
25.6
|
1.0
|
C16
|
A:25I602
|
1.4
|
29.0
|
1.0
|
C08
|
A:25I602
|
2.4
|
29.6
|
1.0
|
C17
|
A:25I602
|
2.4
|
26.8
|
1.0
|
C09
|
A:25I602
|
2.9
|
30.4
|
1.0
|
C10
|
A:25I602
|
2.9
|
26.4
|
1.0
|
CE1
|
A:TYR462
|
3.1
|
30.9
|
1.0
|
N01
|
A:25I602
|
3.1
|
26.0
|
1.0
|
CD1
|
A:TYR462
|
3.2
|
29.1
|
1.0
|
O
|
A:GLY460
|
3.2
|
23.1
|
1.0
|
C07
|
A:25I602
|
3.6
|
29.8
|
1.0
|
CD2
|
A:TYR455
|
3.6
|
28.9
|
1.0
|
C18
|
A:25I602
|
3.6
|
25.8
|
1.0
|
O02
|
A:25I602
|
3.8
|
30.4
|
1.0
|
CE2
|
A:TYR455
|
3.9
|
27.7
|
1.0
|
CZ
|
A:TYR462
|
4.0
|
29.7
|
1.0
|
C06
|
A:25I602
|
4.1
|
29.0
|
1.0
|
CG
|
A:TYR462
|
4.2
|
29.8
|
1.0
|
C
|
A:GLY460
|
4.2
|
26.4
|
1.0
|
C13
|
A:25I602
|
4.3
|
30.4
|
1.0
|
C11
|
A:25I602
|
4.4
|
28.2
|
1.0
|
N
|
A:GLY460
|
4.5
|
26.8
|
1.0
|
O
|
A:GLY458
|
4.6
|
23.8
|
1.0
|
OH
|
A:TYR462
|
4.6
|
32.3
|
1.0
|
OE2
|
A:GLU335
|
4.8
|
35.9
|
1.0
|
CG
|
A:TYR455
|
4.8
|
29.6
|
1.0
|
CE2
|
A:TYR462
|
4.8
|
29.8
|
1.0
|
CD2
|
A:TYR462
|
4.9
|
29.0
|
1.0
|
CB
|
A:TYR462
|
4.9
|
27.3
|
1.0
|
|
Reference:
X.Y.Wang,
J.Zhou,
B.L.Xu.
Mutated Human Adp-Ribosyltransferase 2 (PARP2) Catalytic Domain Bound to Approved Drug Fluzoparib To Be Published.
Page generated: Fri Aug 2 20:07:57 2024
|